SMAD4 that forms a heterotrimer with SMAD2 and SMAD3 to exert transcriptional activity plays a crucial role in carcinogenesis [35], and loss of the SMAD4 gene occurs in about 30% of CRC [36]. This evidence concerns the gene SMAD2 and colorectal carcinoma.